Current portfolio

Egle Therapeutics

Egle is developing a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Treg starving

  • Sektor
    Healthcare
  • Land
    France
  • Fond
    LSP 7
  • Entry
    2021
  • Web
Logo
EQT logo